Adaptimmune Therapeutics
-$0.04 (-1.11%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.
About ADAP
Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors.
CEO
Adrian Rawcliffe
Employees
462
Headquarters
Abingdon, Oxfordshire
Founded
2014
ADAP Key Statistics
Market Cap
721.07M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
624.03K
High Today
$3.64
Low Today
$3.55
Open Price
$3.57
Volume
348.67K
52 Week High
$10.93
52 Week Low
$3.37
Analyst Ratings
50%
of 8 ratings
Buy
37.5%
Hold
50%
Sell
12.5%
ADAP Earnings
-$0.32
-$0.21
-$0.11
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 9, After Hours